Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02538029 · ClinicalTrials.gov registry record · NA

The Effects of Dual Task Training in Individuals With Parkinson's Disease

A NA study of Parkinson's Disease, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT02538029 is a NA study of Parkinson's Disease that has completed, run by The Cleveland Clinic. The registered enrollment target is 45 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02538029, a NA study of Parkinson's Disease, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The primary aim of the proposed project is to characterize dual tasking (DT) deficits to improve motor, cognitive, and quality of life outcomes in individuals with Parkinson's disease (PD). Phase 1 of the intervention will involve an in-depth gait analysis on 15 individuals with PD. This gait analysis will utilize the Computer Assisted Rehabilitation Environment (CAREN) system, a virtual reality system with a fully integrated 3-D motion capture system. The purpose of Phase 1 is to generalize characteristics of gait and postural control during specific DT conditions. Phase 2 (N=20) involves the clinical translation of these findings. This phase will involve creating a clinical intervention based on the objective information gathered the CAREN system. The intervention will take place 3x/week for a total of 8 weeks. Interventional groups will include: 1) DT clinical group (N=10) and 2) Single task group (N=10). Outcome measures will be used at the beginning and end of the intervention to assess the feasibility and efficacy of the intervention.

Conditions Studied

Parkinson's Disease

Interventions

  • BEHAVIORAL Dual Task Group
  • BEHAVIORAL Single Task Group

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2015-08
Est. Completion 2017-08-16
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02538029

The ClinicalTrials.gov registry entry for NCT02538029 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (93% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which Dual Task Group is the first listed.

NCT02538029 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02538029 about?

NCT02538029 is a clinical study titled "The Effects of Dual Task Training in Individuals With Parkinson's Disease". The primary aim of the proposed project is to characterize dual tasking (DT) deficits to improve motor, cognitive, and quality of life outcomes in individuals with Parkinson's disease (PD). Phase 1 of the intervention will involve an in-depth gait analysis on 15 individuals with PD. This gait analys...

What is the current status of trial NCT02538029?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-08. Estimated completion is 2017-08-16.

What conditions does trial NCT02538029 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02538029?

The interventions under investigation include: Dual Task Group (BEHAVIORAL), Single Task Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02538029?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02538029 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.